Sonoma Pharmaceuticals, Inc.
(NASDAQ : SNOA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 0.14%29.1114.1%$171.29m
ICLRICON plc -0.40%228.294.2%$156.08m
JAZZJazz Pharmaceuticals Plc 0.56%180.182.2%$142.95m
HZNPHorizon Therapeutics Plc 1.24%93.285.5%$126.07m
CTLTCatalent, Inc. 0.53%103.242.1%$106.21m
BHCBausch Health Cos., Inc. 0.24%29.140.0%$91.90m
SAVACassava Sciences, Inc. 1.03%41.340.0%$56.35m
UTHRUnited Therapeutics Corp. -0.18%197.5214.0%$55.55m
PRGOPerrigo Co. Plc 0.53%46.116.9%$50.02m
BLRXBioLineRx Ltd. 0.35%2.860.8%$39.10m
ARGXargenx SE 2.25%278.430.0%$39.09m
SAGESAGE Therapeutics, Inc. 0.24%71.037.6%$33.68m
PCRXPacira Biosciences, Inc. -0.15%62.129.9%$30.60m
AXSMAxsome Therapeutics, Inc. 0.21%58.551.9%$26.85m
RVMDRevolution Medicines, Inc. 0.47%32.140.0%$23.49m

Company Profile

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Woodstock, GA.